ImmunologybioRxivPreprint
Agonistic anti-CD40 converts Tregs into Type 1 effectors within the tumor micro-environment
V. Maltez, C. Arora, R. Sor…·K. T. Byrne
This study shows that agonistic anti-CD40 converts Tregs into Type 1 effectors in the tumor microenvironment via IL-12 and IFN-γ signaling from dendritic cells.
DOI 10.1101/2022.10.17.512537